|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-4-9
|
|
pubmed:abstractText |
In resource limited settings patients on antiretroviral treatment who develop stavudine induced hyperlactatemia are often switched to zidovudine on the basis of published studies that demonstrate that this agent can be a safe alternative.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1729-0503
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
133-4
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19357764-Acidosis, Lactic,
pubmed-meshheading:19357764-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:19357764-Anti-HIV Agents,
pubmed-meshheading:19357764-Female,
pubmed-meshheading:19357764-Humans,
pubmed-meshheading:19357764-Middle Aged,
pubmed-meshheading:19357764-Stavudine,
pubmed-meshheading:19357764-Treatment Outcome,
pubmed-meshheading:19357764-Uganda,
pubmed-meshheading:19357764-Zidovudine
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Is it safe to switch from stavudine to zidovudine after developing symptomatic hyperlactatemia?
|
|
pubmed:affiliation |
Infectious Diseases Institute, Kampala, Uganda. bcastelnuovo@idi.co.ug
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
